Introduction: The Larner College of Medicine has steadily transitioned to primarily active learning-based instruction. Although evaluations praise session formats, students often highlight difficulties in synthesizing preparatory materials to integrate biochemical pathways. A student/faculty collaboration led to the development of interactive metabolic maps that illustrate pathways and link to a broader framework of metabolism. Methods: A review of the session materials identified relevant biochemical pathways, and for each pathway, we created a fillable visual diagram to highlight the interactions between all substrates, enzymes, and cofactors. Implementation of the metabolic maps began for first-year medical students in fall 2022. Evaluation data included standard student session evaluations (Likert scale and qualitative comments) and a survey specific to the metabolic maps. Results: After implementing the maps, student ratings of biochemistry/metabolism session materials significantly improved (3.2 ± 1.04 to 4.3 ± 0.87, p < 0.001), and students made positive comments about their effectiveness. Most students (77.8%) used the metabolic maps to aid in studying biochemistry content for exams and found the metabolic maps important for integrating information about metabolic pathways. The median performance on metabolism-specific questions was higher, although not statistically significant (69.23 to 77.28, ns). Discussion: The implementation of integrated metabolic maps improved student satisfaction of biochemistry/metabolism session materials. Limitations include confounding factors related to student population differences and other simultaneous curriculum changes. Implementing interactive visual aids to integrate metabolism pathways and concepts is applicable to any medical curriculum, and other longitudinal topics may benefit from this type of curricular framework.
9 December 2025 in American Journal of Otolaryngology
Retropharyngeal and parapharyngeal abscesses (RPA, PPA) are rare but potentially life-threatening deep neck infections. While both transoral and transcervical drainage are standard treatments, comparative data on their efficacy remain limited. This study evaluates patient characteristics and management strategies to clarify the relative effectiveness and risks of each approach. Retrospective cohort study. Tertiary academic medical center. Adults diagnosed with RPA or PPA from 2013 to 2023 were included. Patient demographics, comorbidities, abscess features, interventions, and outcomes were collected. Surgical approaches were compared using Fisher's exact test and ANOVA. Eighty-four patients (mean age 44.6 years; 45.2 % female) were identified, including 54 RPA (64.3 %) and 30 PPA (35.7 %). Surgical drainage was performed in 55 patients (65.5 %) overall, more often for PPA than RPA (25/30 [83.3 %] vs. 30/54 [55.6 %], p = 0.02). Among surgically treated patients, 18 (32.7 %) underwent transoral drainage and 37 (67.3 %) transcervical. Recurrence occurred in 11 patients: 1 after transoral drainage (5.6 %) and 10 after transcervical (27 %; p = 0.08), more often in PPA than RPA (6/30 [20.0 %] vs. 5/54 [9.3 %]). No recurrences occurred in the antibiotics-only group. Sepsis developed in 3 transoral (22.2 %) and 11 transcervical cases (29.7 %). Patients undergoing transcervical drainage more often had extensive disease and comorbidities (p = 0.01). Overall mortality was 4.8 %, including 3 transcervical patients (8.1 %) with multiple complications. RPA and PPA in adults remain high-risk infections. In selected patients without extensive disease, antibiotics alone or transoral drainage are effective. Transcervical drainage provides exposure for complex disease but is associated with higher complication rates and mortality.
23 September 2025 in Laryngoscope Investigative Otolaryngology
Objectives: To characterize practice patterns and outcomes in the management of low‐ and intermediate‐grade salivary gland carcinoma prior to the existence of treatment guidelines. Methods: Analysis of a registry of patients who underwent parotid and submandibular gland resections for low‐and intermediate‐grade carcinomas between 2010 and 2019. Results: Of all 786 patients included in the study, 726 (92%) had preoperative imaging and 653 (83%) had preoperative biopsy. Of the 729 patients with parotid gland cancer, the majority underwent superficial ( n = 384, 53%) or total ( n = 254, 35%) parotidectomy. In patients with facial nerve preservation, total parotidectomy was associated with a significant increase in transient facial weakness (72/177 (41%) vs. 82/311 (26%), RR 0.65, 95% CI 0.50–0.84, p < 0.05) and permanent facial nerve weakness (23/176 (13%) vs. 16/301 (5%), RR 0.41, 95% CI 0.22–0.75, p < 0.05) compared to superficial parotidectomy. Adjuvant radiation therapy ( RT ) was delivered to 285 (36%) patients. The proportion of patients receiving adjuvant RT declined significantly over the time period from 2015 to 2019 compared to 2010 to 2014 at 162/504 (32%) and 123/282 (44%), respectively ( RR 0.74, 95% CI 0.61–0.89, p < 0.05). When comparing the time periods from 2015 to 2019 and 2010 to 2014, there was no significant difference in local control rates ( RR 0.52, 95% CI 0.26–1.04, p = 0.06) or regional control rates ( RR 0.75, 95% CI 0.26–2.13, p = 0.58). Conclusions: Management of low‐ and intermediate‐grade salivary cancer from 2010 to 2019 was variable, which is expected given the rarity and heterogeneity of the disease and the lack of treatment guidelines prior to 2021. Most patients with parotid malignancies underwent superficial or total parotidectomy. The extent of parotidectomy had an impact on facial nerve function outcomes. Delivery of adjuvant radiation trended down with time. The data presented here will support dissemination of the guidelines and provide data that could inform future trials. Level of Evidence: 2b.
Primary ciliary dyskinesia (PCD) is a rare, genetically heterogeneous disorder of motile cilia that leads to impaired mucociliary clearance and recurrent airway infections. Children with PCD often present with ear and sinus disease resembling common pediatric conditions, yet the true burden and management remain incompletely defined. To address this gap, a systematic search for pediatric cohort studies published between 2020 and 2025 reporting otologic and sinonasal features of PCD was performed. Searches of PubMed, Embase, Scopus, and Web of Science identified 12 eligible studies, encompassing 524 children with confirmed PCD. Data extracted focused on demographics, otologic and sinonasal manifestations, vestibular findings, radiographic imaging, and interventions. Across studies, 60.3% had a history of otitis media and 39.1% had hearing loss, predominantly conductive. Tympanostomy tubes were utilized in more than half of patients, with many requiring multiple sets over time due to recurrent effusions or tube occlusion. Sinonasal disease was nearly universal, with 78.5% demonstrating chronic rhinosinusitis and most reporting nasal congestion and rhinorrhea; nasal polyps were uncommonly noted. Vestibular symptoms were also infrequently assessed but present in some patient cohorts. In conclusion, otologic and sinonasal disease are highly co-prevalent in pediatric PCD, highlighting the need for early recognition, regular surveillance, and standardized outcome reporting to guide long-term management of this complex chronic disease.
Audiovestibular disorders arising from the inner ear (e.g., hearing loss, tinnitus, vertigo) are widely prevalent in the United States. Yet, medical treatments targeting the underlying pathology of these disorders remain scarce. The practice of repurposing FDA-approved drugs for new therapeutic indications has become increasingly common, offering a lower risk route to treatment development with fewer barriers to implementation, as safety profiles are already established. The renin–angiotensin system (RAS) is well known for its role in blood pressure and fluid balance, and its overactivation induces acute and chronic inflammation and oxidative stress. This review discusses existing evidence and proposed otoprotective mechanisms of RAS inhibition, specifically using angiotensin II type 1 receptor blockers (ARBs), which support the repurposing of these medications as novel treatments to affect the inner ear pathologies that underlay hearing loss, tinnitus, and vertigo.
Background/Objectives: Ventriculoperitoneal shunt (VPS) placement alters cerebrospinal (CSF) dynamics and has been associated with hearing changes through pressure transmission via the cochlear aqueduct. Despite the large number of patients undergoing VPS placement annually, associated hearing changes remain poorly characterized. This scoping review aimed to characterize the available evidence on hearing outcomes following VPS placement and identify gaps warranting further investigation. Methods: This scoping review was conducted in accordance with PRISMA-ScR guidelines. PubMed was queried from January 1980 through January 2026. Eligible studies included case reports, case series, and observational cohorts reporting hearing outcomes following VPS placement. Two independent reviewers screened titles, abstracts, and full texts. Risk of bias was assessed using Joanna Briggs critical appraisal tools. Due to heterogeneity in study designs, outcomes metrics, and follow-up duration, quantitative synthesis was not performed. Results: Nineteen studies comprising approximately 200 patients met inclusion criteria. Hearing deterioration and improvement were each reported in 7 studies (36.8%); mixed outcomes were reported in 5 studies (26.3%). Acute hearing changes occurred within 48 h in 3 studies (15.8%), whereas delayed changes were described in 13 studies (68.4%). Overall quality of evidence was low. Conclusions: This scoping review identifies VPS placement as a clinically underrecognized contributor to hearing change. Current evidence is heterogenous and dominated by low level studies, underscoring the need for prospective investigation with standardized audiologic protocols. Preoperative audiograms should be considered when possible, as well as a low threshold for audiology referral for postoperative hearing concerns.